Published in
Centers for Disease Control and Prevention, Emerging Infectious Diseases, 3(16), p. 493-496
Links
- ORCID
- Centers for Disease Control and Prevention | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [citeseerx.ist.psu.edu] | PDF
- [citeseerx.ist.psu.edu] | PDF
- [www.cdc.gov] | PDF
Tools
Rare Influenza A (H3N2) Variants with Reduced Sensitivity to Antiviral Drugs
Journal article published in 2010 by
Clyde Dapat,
Yasushi Suzuki,
Reiko Saito,
Yadanar Kyaw,
Yi Yi Myint,
Nay Lin,
Htun Naing Oo,
Khin Yi Oo,
Ne Win,
Makoto Naito,
Go Hasegawa,
Isolde C. Dapat,
Hassan Zaraket 
,
Tatiana Baranovich,
Makoto Nishikawa
and other authors.
,
Tatiana Baranovich,
Makoto Nishikawa
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
In 2007 and 2008 in Myanmar, we detected influenza viruses A (H3N2) that exhibited reduced sensitivity to both zanamivir and amantadine. These rare and naturally occurring viruses harbored a novel Q136K mutation in neuraminidase and S31N mutation in M2.